The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 261.00
Bid: 261.00
Ask: 261.40
Change: 7.20 (2.84%)
Spread: 0.40 (0.153%)
Open: 251.60
High: 262.40
Low: 250.80
Prev. Close: 253.80
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

8 Mar 2024 15:45

RNS Number : 2209G
Man Group plc
08 March 2024
 

Man Group plc (the "Company")

In compliance with Listing Rule 9.6.1 the following documents have been submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk#/nsm/nationalstoragemechanism.

1. Annual Report for the year ended 31 December 2023 (the "Annual Report")

2. Notice of the 2024 Annual General Meeting (the "AGM Notice")

3. Form of Proxy for the 2024 Annual General Meeting

The Annual Report and AGM Notice are also available on the Company's website at www.man.com/investor-relations. The Annual Report will be available in ESEF compliant format on the National Storage Mechanism and on the Company's website, on or around 13 March 2024.

The Company confirms that, in compliance with DTR 6.3.5(1A), the regulated information required under DTR 6.3.5 is available in unedited full text within the Annual Report available on the National Storage Mechanism and, in compliance with DTR 6.3.5(3), is available on the Company's website as noted above.

Enquiries

 

Georgiana Brunner

Head of Communications

+44 (0)20 7144 1000

media@man.com

 

Karan Shirgaokar

Head of Investor Relations

+44 (0)20 7144 1434

investor.relations@man.com

 

Elizabeth Woods

Company Secretary

+44 (0)20 7144 1733

company.secretarial@man.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSBUGDXCDGDGSI
Date   Source Headline
24th Aug 20215:45 pmRNSTransaction in Own Shares
24th Aug 202112:21 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
24th Aug 202112:17 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
23rd Aug 20216:24 pmRNSTransaction in Own Shares
23rd Aug 20211:49 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
23rd Aug 20211:47 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20215:53 pmRNSTransaction in Own Shares
20th Aug 20218:57 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20218:56 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 20215:55 pmRNSTransaction in Own Shares
19th Aug 202112:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 202112:23 pmGNWMan Group PLC : Form 8.3 - Vectura Group plc
19th Aug 20219:00 amRNSInterim Dividend Conversion Rate
18th Aug 20215:25 pmRNSTransaction in Own Shares
18th Aug 20218:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
17th Aug 20216:03 pmRNSTransaction in Own Shares
17th Aug 202110:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
16th Aug 20215:59 pmRNSTransaction in Own Shares
16th Aug 202112:05 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Aug 20215:20 pmRNSTransaction in Own Shares
13th Aug 202111:05 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
12th Aug 20215:57 pmRNSTransaction in Own Shares
12th Aug 202111:23 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20215:45 pmRNSTransaction in Own Shares
11th Aug 202110:36 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20217:00 amRNSTransaction in Own Shares
10th Aug 202111:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Aug 20217:00 amRNSShare buyback programme of up to $100 million
9th Aug 20219:41 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Aug 20219:39 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
6th Aug 20219:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:30 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:26 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
4th Aug 20212:12 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
4th Aug 20212:09 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Aug 202112:28 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
3rd Aug 202112:25 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:42 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Aug 20211:38 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:34 pmGNWMan Group PLC : Form 8.3 - John Laing Group plc
2nd Aug 20217:00 amRNSTotal Voting Rights
30th Jul 20211:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
30th Jul 20211:25 pmGNWMan Group PLC : Form 8.3 - St.Modwen Properties plc
30th Jul 20211:20 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
29th Jul 20214:20 pmRNSDirector/PDMR Shareholding
29th Jul 20211:56 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
29th Jul 20211:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
29th Jul 20211:51 pmGNWMan Group PLC : Form 8.3 - Morrison (WM) Supermarket plc
28th Jul 20216:01 pmRNSTransaction in Own Shares
28th Jul 20211:40 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.